New OTC Nexium approved

Share this article:

Pfizer's consumer portfolio now includes a 24-hour version of over-the-counter Nexium. The company announced Friday that the FDA greenlighted the no-prescription heartburn medication.

The company is also pursuing an OTC version of its former prescription blockbuster cholesterol medication Lipitor.

Pfizer acquired worldwide marketing rights to the non-Rx version of AZ's blockbuster proton-pump inhibitor in 2012. Deal terms called for a $250-million upfront payment.

Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.